Neurotrophin-3 levels in the cerebrospinal fluid of patients with schizophrenia or medical illness

Keywords

Cerebrospinal fluidSchizophrenia (object-oriented programming)PathogenesisNeurotrophinMedicineNeurotrophin-3PsychiatryInternal medicineNeurotrophic factorsBrain-derived neurotrophic factorReceptor

Affiliated Institutions

University of North Carolina at Chapel Hill US

Related Publications

A Diagnostic Interview

Jean Endicott

The Schedule for Affective Disorders and Schizophrenia (SADS) was developed to reduce information variance in both the descriptive and diagnostic evaluation of a subject. The SA...

1978 Archives of General Psychiatry 5704 citations

Non‐alcoholic steatohepatitis: Definitions and pathogenesis

CP Day , S SAKSENA

The term 'non-alcoholic steatohepatitis' or NASH was first used by Ludwig et al. in 1980 to describe 'the pathological and clinical features of non-alcoholic disease of the live...

2002 Journal of Gastroenterology and Hepat... 187 citations

Publication Info

Year: 1997
Type: article
Volume: 73
Issue: 1-2
Pages: 109-113
Citations: 22
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Neurotrophin-3 levels in the cerebrospinal fluid of patients with schizophrenia or medical illness

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

OpenAlex

Cite This

APA Style

                            
                                
                                    John H. Gilmore, 
                                
                                    L. Fredrik Jarskog, 
                                
                                    John C. Lindgren
                                
                                et al.
                            
                            (1997). 
                            Neurotrophin-3 levels in the cerebrospinal fluid of patients with schizophrenia or medical illness. 
                            Psychiatry Research
                            , 73
                            (1-2)
                            , 109-113.
                            https://doi.org/10.1016/s0165-1781(97)00116-9
                        

Identifiers

DOI: 10.1016/s0165-1781(97)00116-9